CA2413742A1 - Activite de liaison au prion dans le serum et dans les proteines - Google Patents
Activite de liaison au prion dans le serum et dans les proteines Download PDFInfo
- Publication number
- CA2413742A1 CA2413742A1 CA002413742A CA2413742A CA2413742A1 CA 2413742 A1 CA2413742 A1 CA 2413742A1 CA 002413742 A CA002413742 A CA 002413742A CA 2413742 A CA2413742 A CA 2413742A CA 2413742 A1 CA2413742 A1 CA 2413742A1
- Authority
- CA
- Canada
- Prior art keywords
- prpsc
- factor
- prion
- plasminogen
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/484—Plasmin (3.4.21.7)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/968—Plasmin, i.e. fibrinolysin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2828—Prion diseases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Food Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
L'invention concerne des procédés et des outils destinés à concentrer, à détecter et à quantifier des protéines prion pathologiques ainsi que des agents à utiliser dans ladite détection et/ou dans la prévention ou dans le traitement des maladies à prion. Ces agents sont des facteurs dotés d'activités de liaison au prion que l'on trouve dans le sérum sanguin et dans le plasma sanguin.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2000/000849 WO2001023425A1 (fr) | 1999-09-28 | 2000-06-26 | Facteurs ayant une activite de liaison au prion dans du serum ou du plasma et agents permettant de detecter l'encephalopathie spongiforme transmissible |
IBPCT/IB00/00849 | 2000-06-26 | ||
PCT/EP2001/003481 WO2002000713A1 (fr) | 2000-06-26 | 2001-03-27 | Activite de liaison au prion dans le serum et dans le plasma designes comme plasminogene et fibrinogene |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2413742A1 true CA2413742A1 (fr) | 2002-01-03 |
Family
ID=11003939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002413742A Abandoned CA2413742A1 (fr) | 2000-06-26 | 2001-03-27 | Activite de liaison au prion dans le serum et dans les proteines |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1294759A1 (fr) |
JP (1) | JP2004501626A (fr) |
AU (1) | AU2001250406A1 (fr) |
BR (1) | BR0111975A (fr) |
CA (1) | CA2413742A1 (fr) |
WO (1) | WO2002000713A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2309410C2 (ru) * | 2002-02-28 | 2007-10-27 | Майкроусенс Байофейдж Лимитед | Связывание патологических форм прионовых белков |
DE10230141B4 (de) * | 2002-07-04 | 2004-07-15 | Priontype Gmbh | Verfahren und Kit zur Anreicherung und zum Nachweis von veränderten Prion-Proteinen (PrPSc) |
US7482172B2 (en) | 2005-09-19 | 2009-01-27 | Ortho-Clinical Diagnostics, Inc. | Peptides for discrimination of prions |
AU2005209592B2 (en) | 2004-09-30 | 2012-07-12 | Ortho-Clinical Diagnostics, Inc. | Peptides for discrimination of prions |
KR20090008176A (ko) * | 2005-12-08 | 2009-01-21 | 사우스다코타주립대학 | 감염성 프리온의 시험관 내 증식 및 검출 방법 |
FR2940446A1 (fr) * | 2008-12-22 | 2010-06-25 | Lfb Biotechnologies | Procede de detection d'une infection par prion |
FR2973114A1 (fr) | 2011-03-21 | 2012-09-28 | Ets Francais Du Sang | Nanobilles recouvertes de plasminogene comme support direct d'amplification cyclique de la proteine prion prpsc |
EP3064757B1 (fr) | 2015-03-05 | 2018-11-14 | Continental Automotive GmbH | Procédé de fabrication d'un injecteur pour fluide et ledit injecteur |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19925073C2 (de) * | 1999-06-01 | 2001-07-19 | Stefan Weiss | Nucleinsäuremoleküle mit spezifischer Erkennung von nativem PrP·S··c·, Herstellung und Verwendung |
JP2003521477A (ja) * | 1999-06-23 | 2003-07-15 | カプリオン ファーマシューティカルズ インコーポレーティッド | プリオン蛋白質ペプチドおよびその使用 |
CA2385743A1 (fr) * | 1999-09-28 | 2001-04-05 | Universitat Zurich | Facteurs ayant une activite de liaison au prion dans du serum ou du plasma et agents permettant de detecter l'encephalopathie spongiforme transmissible |
-
2001
- 2001-03-27 CA CA002413742A patent/CA2413742A1/fr not_active Abandoned
- 2001-03-27 EP EP01923701A patent/EP1294759A1/fr not_active Withdrawn
- 2001-03-27 WO PCT/EP2001/003481 patent/WO2002000713A1/fr not_active Application Discontinuation
- 2001-03-27 AU AU2001250406A patent/AU2001250406A1/en not_active Abandoned
- 2001-03-27 BR BR0111975-3A patent/BR0111975A/pt not_active IP Right Cessation
- 2001-03-27 JP JP2002505835A patent/JP2004501626A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1294759A1 (fr) | 2003-03-26 |
BR0111975A (pt) | 2003-07-01 |
JP2004501626A (ja) | 2004-01-22 |
WO2002000713A1 (fr) | 2002-01-03 |
AU2001250406A1 (en) | 2002-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20020004586A1 (en) | Prion-binding activity in serum and proteins | |
US10288627B2 (en) | Assay for prions | |
US7807386B2 (en) | Peptides for discrimination of prions | |
EP0931551B1 (fr) | Méthode pour produir des thérapeutiques pour l'Encéphalopathie Spongiforme transmissible, produits sanguins et tissulaires non-infectieux et procédés pour les obtenir | |
CA2413742A1 (fr) | Activite de liaison au prion dans le serum et dans les proteines | |
JP2004529314A (ja) | プリオン株を決定する方法 | |
EP1435521B1 (fr) | Détéction et diagnostic de l'encephalopathie spongiforme transmissible | |
JP4837353B2 (ja) | プリオンの区別のためのペプチド | |
Cervenakova et al. | Advances in screening test development for transmissible spongiform encephalopathies | |
US8663943B2 (en) | Antibodies for discrimination of prions | |
EP1445615A1 (fr) | Procede pour discrimination des prions infectieux et non infectieux | |
Stone | Physicochemical characterisation of disease associated abnormal prion proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |